SORL1 and Merkel cell skin cancer: The self-peptide gp250 positively selected AND TCR, supporting our previous in vitro study (Lo and Allen, 2013), and also selected many other TCRs that have been reported as good MCC responders (Hedrick et al., 1988; McHeyzer-Williams et al., 1999).